Depreciation of PROVECTUS BIOPHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
PROVECTUS BIOPHARMACEUTICALS, INC. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2010 to 31 Mar 2025.
  • PROVECTUS BIOPHARMACEUTICALS, INC. Depreciation for the quarter ending 31 Mar 2025 was $467, a 79% decline year-over-year.
  • PROVECTUS BIOPHARMACEUTICALS, INC. annual Depreciation for 2024 was $7,157, a 20% decline from 2023.
  • PROVECTUS BIOPHARMACEUTICALS, INC. annual Depreciation for 2023 was $8,921, a 18% decline from 2022.
  • PROVECTUS BIOPHARMACEUTICALS, INC. annual Depreciation for 2022 was $10,895, a 15% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $467 -$1,764 -79% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $2,231 +$1 +0.04% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $2,230 -$988 -31% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $3,218 +$2 +0.06% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $3,216 -$307 -8.7% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $3,523 -$17,788 -83% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q1 2019 $21,311 +$17,787 +505% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q1 2018 $3,524 +$893 +34% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q1 2017 $2,631 -$865 -25% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q1 2016 $3,496 +$307 +9.6% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $3,189 +$1,473 +86% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $1,716 +$166 +11% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q1 2013 $1,550 +$272 +21% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $1,278 -$590 -32% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q1 2011 $1,868 01 Jan 2011 31 Mar 2011 10-Q 09 May 2012 2012 Q1

PROVECTUS BIOPHARMACEUTICALS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $7,157 -$1,764 -20% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $8,921 -$1,974 -18% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $10,895 -$1,970 -15% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $12,865 -$818 -6% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $13,683 -$409 -2.9% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $14,092 -$1 -0.01% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021 2020 FY
2018 $14,093 -$1,771 -11% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
2017 $15,864 +$2,752 +21% 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
2016 $13,112 -$53 -0.4% 01 Jan 2016 31 Dec 2016 10-K 23 Mar 2018 2017 FY
2015 $13,165 +$4,633 +54% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017 2016 FY
2014 $8,532 +$2,166 +34% 01 Jan 2014 31 Dec 2014 10-K 31 Mar 2017 2016 FY
2013 $6,366 +$199 +3.2% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2016 2015 FY
2012 $6,167 -$1,189 -16% 01 Jan 2012 31 Dec 2012 10-K 12 Mar 2015 2014 FY
2011 $7,356 -$1,499 -17% 01 Jan 2011 31 Dec 2011 10-K 13 Mar 2014 2013 FY
2010 $8,855 01 Jan 2010 31 Dec 2010 10-K 14 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.